View Item 

Show simple item record

The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers
dc.contributor.authorTapper, Elliot B.
dc.contributor.authorHao, Shengchen
dc.contributor.authorLin, Menghan
dc.contributor.authorMafi, John N.
dc.contributor.authorMcCurdy, Heather
dc.contributor.authorParikh, Neehar D.
dc.contributor.authorLok, Anna S.
dc.date.accessioned2020-02-05T15:07:28Z
dc.date.availableWITHHELD_12_MONTHS
dc.date.available2020-02-05T15:07:28Z
dc.date.issued2020-01
dc.identifier.citationTapper, Elliot B.; Hao, Shengchen; Lin, Menghan; Mafi, John N.; McCurdy, Heather; Parikh, Neehar D.; Lok, Anna S. (2020). "The Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers." Hepatology (1): 225-234.
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/2027.42/153696
dc.publisherWiley Periodicals, Inc.
dc.titleThe Quality and Outcomes of Care Provided to Patients with Cirrhosis by Advanced Practice Providers
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153696/1/hep30695.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153696/2/hep30695_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153696/3/hep30695-sup-0001-TableS1-S6.pdf
dc.identifier.doi10.1002/hep.30695
dc.identifier.sourceHepatology
dc.identifier.citedreferenceBajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia‐Tsao G, et al. The 3‐month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology 2016; 64: 200 ‐ 208.
dc.identifier.citedreferenceArguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB. Cost‐effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol 2002; 97: 2441 ‐ 2452.
dc.identifier.citedreferenceBass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 1071 ‐ 1081.
dc.identifier.citedreferenceTapper EB. Building effective quality improvement programs for liver disease: a systematic review of quality improvement initiatives. Clin Gastroenterol Hepatol 2016; 14: 1256 ‐ 1265.e1253.
dc.identifier.citedreferenceMellinger JL, Volk ML. Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol 2013; 11: 217 ‐ 223.
dc.identifier.citedreferenceMellinger JL, Moser S, Welsh DE, Yosef MT, Van T, McCurdy H, et al. Access to subspecialty care and survival among patients with liver disease. Am J Gastroenterol 2016; 111: 838 ‐ 844.
dc.identifier.citedreferenceHorrocks S, Anderson E, Salisbury C. Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. BMJ 2002; 324: 819 ‐ 823.
dc.identifier.citedreferenceMafi JN, Wee CC, Davis RB, Landon BE. Comparing use of low‐value health care services among US advanced practice clinicians and physicians providing value: advanced practice clinicians versus physicians. Ann Int Med 2016; 165: 237 ‐ 244.
dc.identifier.citedreferenceWilson IB, Landon BE, Hirschhorn LR, McInnes K, Ding L, Marsden PV, et al. Quality of HIV care provided by nurse practitioners, physician assistants, and physicians. Ann Int Med 2005; 143: 729 ‐ 736.
dc.identifier.citedreferenceBlue L, Lang E, McMurray JJ, Davie AP, McDonagh TA, Murdoch DR, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 2001; 323: 715 ‐ 718.
dc.identifier.citedreferenceDavila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus‐infected veterans in the United States. Ann Intern Med 2011; 154: 85 ‐ 93.
dc.identifier.citedreferenceKanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, et al. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology 2011; 140: 1182 ‐ 1188.e1181.
dc.identifier.citedreferenceBeste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001‐2013. Gastroenterology 2015; 149: 1471 ‐ 1482.e1475.
dc.identifier.citedreferenceDeyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD‐9‐CM administrative databases. J Clin Epidemiol 1992; 45: 613 ‐ 619.
dc.identifier.citedreferenceFine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496 ‐ 509.
dc.identifier.citedreferenceAnderson JR. Analysis of survival by tumor response. J Clin Oncol 1983; 1: 710 ‐ 719.
dc.identifier.citedreferenceSingal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta‐analysis. PLoS Med 2014; 11: e1001624.
dc.identifier.citedreferenceSingal AG, Tiro JA, Murphy CC, Marrero JA, McCallister K, Fullington H, et al. Mailed outreach invitations significantly improve HCC surveillance rates in patients with cirrhosis: a randomized clinical trial. Hepatology 2019; 69: 121 ‐ 130.
dc.identifier.citedreferenceTapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Chang M, Lai M. A quality improvement initiative reduces 30‐day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol 2016; 14: 753 ‐ 759.
dc.identifier.citedreferenceMundinger MO, Kane RL, Lenz ER, Totten AM, Tsai WY, Cleary PD, et al. Primary care outcomes in patients treated by nurse practitioners or physicians: a randomized trial. JAMA 2000; 283: 59 ‐ 68.
dc.identifier.citedreferenceSwan M, Ferguson S, Chang A, Larson E, Smaldone A. Quality of primary care by advanced practice nurses: a systematic review. Int J Qual Health Care 2015; 27: 396 ‐ 404.
dc.identifier.citedreferenceWong R, Liu B, Bhuket T. Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross‐sectional analysis of 2011–2014 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 2017; 46: 974 ‐ 980.
dc.identifier.citedreferenceEstes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018; 67: 123 ‐ 133.
dc.identifier.citedreferenceBeste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001‐2013. Gastroenterology 2015; 149: 1471 ‐ 1482.e1475.
dc.identifier.citedreferenceTapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999‐2016: observational study. BMJ 2018; 362: k2817.
dc.identifier.citedreferenceMellinger JL, Shedden K, Winder GS, Tapper E, Adams M, Fontana RJ, et al. The high burden of alcoholic cirrhosis in privately insured persons in the United States. Hepatology 2018; 68: 872 ‐ 882.
dc.identifier.citedreferenceBajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, et al. The multi‐dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 2011; 106: 1646 ‐ 1653.
dc.identifier.citedreferenceRakoski MO, McCammon RJ, Piette JD, Iwashyna TJ, Marrero JA, Lok AS, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology 2012; 55: 184 ‐ 191.
dc.identifier.citedreferenceKanwal F, Kramer J, Asch SM, El‐Serag H, Spiegel BM, Edmundowicz S, et al. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol 2010; 8: 709 ‐ 717.
dc.identifier.citedreferenceSingal AG, Mittal S, Yerokun OA, Ahn C, Marrero JA, Yopp AC, et al. Hepatocellular carcinoma screening associated with early tumor detection and improved survival among patients with cirrhosis in the US. Am J Med 2017; 130: 1099 ‐ 1106.e1091.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep30695.pdf
Size:
330.6KB
Format:
PDF
View/Open
Name:
hep30695_am.pdf
Size:
277.5KB
Format:
PDF
View/Open
Name:
hep30695-sup-0001-TableS1-S6.pdf
Size:
153.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.